Anavex Life Sciences
AVXL
93 hedge funds and large institutions have $75.8M invested in Anavex Life Sciences in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 5 closing their positions.
300% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 5
31% more capital invested
Capital invested by funds: $57.7M → $75.8M (+$18.1M)
26% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 23
19% more funds holding
Funds holding: 78 → 93 (+15)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.18% less ownership
Funds ownership: 21.08% → 20.89% (-0.18%)
41% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $2.59M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$4.11M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$1.18M |
| 3 |
BlackRock
New York
|
+$843K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$701K |
| 5 |
Renaissance Technologies
New York
|
+$333K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$861K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$780K |
| 3 |
Squarepoint
New York
|
-$256K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$244K |
| 5 |
Jane Street
New York
|
-$230K |
AVXL Hedge Fund Activity: Q4 2020 in Review
93 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2020, worth a combined $75.8M — up 31% from $57.7M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new AVXL positions and 5 closed out — a net gain of 15 holders — while 29 added to existing stakes and 23 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $4.11M. The largest seller was Susquehanna International Group, cutting an estimated $861K.
- 93 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2020, up from 78 in Q3 2020.
- Funds reported $75.8M of Anavex Life Sciences stock for Q4 2020, up 31% quarter-over-quarter.
- 20 funds opened new Anavex Life Sciences positions in Q4 2020 and 5 closed out, a net change of +15 holders.
- The largest Anavex Life Sciences buyer in Q4 2020 was Perceptive Advisors, an estimated $4.11M added.
- The largest Anavex Life Sciences seller in Q4 2020 was Susquehanna International Group, an estimated $861K sold.
Based on aggregated 13F filings for Q4 2020.